Singapore markets closed

Mersana Therapeutics, Inc. (MRSN)

NasdaqGS - NasdaqGS Real-time price. Currency in USD
Add to watchlist
4.4800-0.0100 (-0.22%)
At close: 04:00PM EDT
4.4800 0.00 (0.00%)
After hours: 05:59PM EDT
Show:
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
36,855
36,855
26,581
43
828
Operating expenses
Research development
148,269
148,269
173,385
132,013
67,036
Selling general and administrative
59,543
59,543
56,963
36,888
21,902
Total operating expenses
207,812
207,812
230,348
168,901
88,938
Operating income or loss
-170,957
-170,957
-203,767
-168,858
-88,110
Interest expense
4,073
4,073
3,328
1,267
359
Total other income/expenses net
-8,713
-8,713
-
-
-
Income before tax
-171,670
-171,670
-204,212
-170,060
-88,045
Income from continuing operations
-171,670
-171,670
-204,212
-170,060
-88,045
Net income
-171,670
-171,670
-204,212
-170,060
-88,045
Net income available to common shareholders
-171,670
-171,670
-204,212
-170,060
-88,045
Basic EPS
-1.43
-1.48
-2.18
-2.41
-1.43
Diluted EPS
-1.43
-1.48
-2.18
-2.41
-1.43
Basic average shares
61,485
116,113
93,654
70,581
61,485
Diluted average shares
61,485
116,113
93,654
70,581
61,485